Egypt vs Rwanda: Cause of death, by non-communicable diseases, ages 60+, female
Egypt
73.1%
in 2021
Rwanda
73.2%
in 2021
Egypt rank
103rd
Rwanda rank
102nd
Cause of death, by non-communicable diseases, ages 60+, female over time
- Egypt
- Rwanda
How they compare
Rwanda currently reports 73.2% against 73.1% in Egypt, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Egypt ahead.
Egypt ranks 103rd and Rwanda ranks 102nd of 185 countries.
Egypt has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Egypt | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95.1% | 72.3% | 22.8% | Egypt |
| 2010s | 95.5% | 75.8% | 19.7% | Egypt |
| 2020s | 77.3% | 75.1% | 2.2% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Egypt or Rwanda?
- Rwanda, at 73.2% against 73.1% in Egypt as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Egypt and Rwanda?
- 0.1%, with Rwanda ahead.
- How many years of comparable data are there for Egypt and Rwanda?
- 6 years are reported by both, from 2000 to 2021.
- How do Egypt and Rwanda rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Egypt ranks 103rd and Rwanda ranks 102nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.